Optimal Prescribing of Statins to Reduce Cardiovascular Disease
-
Published:2023-12
Issue:12
Volume:136
Page:1133-1135
-
ISSN:0002-9343
-
Container-title:The American Journal of Medicine
-
language:en
-
Short-container-title:The American Journal of Medicine
Author:
Schade David S.ORCID,
Duro Teodor,
Eaton R. Philip
Reference15 articles.
1. Long-term persistence in use of statin therapy in elderly patients;Benner;JAMA,2002
2. Prescribing statins to reduce cardiovascular disease: 10 common misconceptions;Schade;Am J Med,2019
3. Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity monotherapy in patients with atherosclerotic cardiovascular disease (RACING): A randomized, open-label, non-inferiority trial;Kim;Lancet,2022
4. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: A meta-analysis;Preiss;JAMA,2011
5. Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract;Mach;Eur Heart J,2018